The study describes procedures that were used to develop a highly sensitive enzyme-linked immunosorbent assay (ELISA) for the quantitation of a trichothecene mycotoxin, 3-acetyldeoxynivalenol (3-AcDON), in barley. Polyclonal antibodies were produced in rabbits immunized with a conjugate of 3-AcDON and human serum albumin linked by an ester linkage (hemisuccinate bridge). High anti-3-AcDON titers were obtained after multiple immunizations. However, only a negligible degree of inhibition was obtained with 3-AcDON in a competitive ELISA when the coating conjugate contained the same ester linkage group (hemiglutarate bridge) as the immunogen. The use of a conjugate containing a heterologous ether linkage (O-methylcarboxyl bridge) compared to that of the immunogen yielded an inhibition curve for 3-AcDON that was highly sensitive (ICso = 0.21 ng/ml) with essentially no interference from the bridging group. This conjugate was synthesized using iodoacetate and l,l'-carbonyldiimidazole chemistries. The assay showed low cross-reactivity with other trichothecenes including several analogs of deoxynivalenol (DON) with the exception of acetylated DON. The ELISA developed on the basis of this new conjugate was able to detect low concentrations of 3-AcDON (16 ppb) in spiked barley without any cleanup treatments.
3-Acetyldeoxynivalenol (3a-acetoxy-7 a, l5-dihydroxy-l2,13-epoxy-trichothec-9-en-8-one;
3-AcDON) is a major secondary metabolite of field fungi such as Fusarium graminearum and Fusarium culmorum (23, 36, 43) . It is one of the monoacetyl analogues of deoxynivalenol (DON, vomitoxin) which belong to a group of trichothecene mycotoxins sharing the 12, 13-epoxy-trichothec-9-eneskeleton ( Figure 1 and Table 1 ). Trichothecenes occur most frequently in wheat, barley, rice, and com with DON-type toxins being the most important in terms of incidence (30) . The adverse effects of DON in animals include feed refusal, emesis, and ultimately reduction in weight gain (36) . In * Author for correspondence: Tel: 204-474-8188; Fax: 204-275-0402. addition, 3-AcDON or another monoacetyl analog of DON, l5-acetyldeoxynivalenol (l5-AcDON), had acute and subacute toxic effects on mice (12, 19, 28) and immunosuppressive effects on rodent and human lymphoid cells (4, 34) . The widespread and high levels of contamination of grains with DON-type toxins and their potential hazardous effects on animals and humans has stimulated considerable research on the development of analytical techniques for detection of this class of toxin. Rapid progress has been made in this area during the past decade, including the development of improved physicochemical methods such as thin-layer chromatography (TLC), gas chromatography-mass spectroscopy (GC-MS), and high-pressure liquid chromatography (HPLC) (for a review, see [29] ) and immunological approaches such as radioimmunoassay (RIA) and enzyme-linked immunosorbent assay (ELISA) (1, 24, 42) . In the last few years, the ELISA and other ELISA-based procedures have gained more acceptance as they offer the advantages of specificity, sensitivity, simplicity, and rapidity, which are important for routine test applications. Several ELISAs for DON detection have been developed utilizing monoclonal or polyclonal anti-DON antibodies, with most of them having high cross-reactivity with 3-AcDON (2, 8, 37) . Only a few assays have been reported for screening 3-AcDON (20, 37) and other acetylated forms of DON (32, 38, 45) . Previous studies have shown that DON and 3-AcDON can be reversibly acetylated and deacetylated in fungal cultures through a microbial transformation pathway (44) . In some Fusarium species, the 3-acetyl form of the toxin frequently co-occurs with the parent alcohol or is even the predominant product (3, 23) . This would suggest that more attention should be directed towards 3-AcDON, especially since DON does not appear to be the sole toxic agent responsible for the adverse effects observed in intoxicated animals (13) . Therefore, the objective of this study was to develop a specific and sensitive immunoassay for 3-AcDON. In the present study, several new 3-AcDON derivatives and protein conjugates were synthesized. They contained bridging lengths, structures, linkage sites, or protein carriers that were different from those of the immunogen. The performance of the assays was evaluated when these conjugates were used and related trichothecenes. The side-chain residues for different toxins used in the present study are listed in Table 1 .
in indirect competitive ELISAs as the plate coating antigens.
On the basis of the results, an assay was developed that minimized the interference of the bridging group and protein carrier. The assay was able to detect low concentrations of 3-AcDON in spiked barley.
MATERIALS AND METHODS

Reagents and materials
All the organic and inorganic chemicals were analytical grade quality. Human serum albumin (HSA, fraction V), chicken egg albumin (ovalbumin, OVA, grade V), alkaline phosphataselabelled goat anti-rabbit IgG, Tween 20, p-nitrophenyl phosphate (pNPP) tablets, complete and incomplete Freund's adjuvant (CFA, IFA, respectively), p-anisaldehyde, succinic anhydride, glutaric anhydride, N-hydroxysuccinimide (NHS), iodoacetic acid, I-methylimidazole, 1,1' -carbonyldiimidazole (CDI), 15-AcDON, nivalenol (NIV) and all other trichothecenes were purchased from Sigma 
Preparation of immunogen
Covalent coupling of 3-AcDON to HSA via a hemisuccinate bridge ( Figure 2 , B1 to Dl). The toxin was first succinylated at the C-15 position (37) to form 15-0-hemisuccinyl-3-AcDON (3-AcDON-HS, B1) by dissolving 10 mg of 3-AcDON in I mlof pyridine and adding 100 mg of succinic anhydride. The mixture was heated at 100°C for 2 h followed by normal-phase (silica) TLC. The chromatography was performed with the developing solvent being a mixture of methanol and chloroform (1 :9, vol/vol). The toxin and its derivative were visualized by spraying with 10% sulfuric acid or 20% aluminum chloride and identified on the basis of their Rfvalues (37) . The toxin derivative, 3-AcDON-HS (BI), was identified when sprayed with aluminum chloride or sulfuric acid as a single blue fluorescent spot or brown spot at RfO.? The Rf value for standard 3-AcDON was 0.8. The data indicated that the esterification reaction went to completion and that only one of the hydroxyl groups of 3-AcDON (C-15) was derivatized (18). 3-AcDON-HS was then coupled to HSA using the active NHS ester method described by Kitagawa et al. (22) with a 50: I molar ratio of toxin-to-protein carrier. The conjugate was purified by filtration on a PD-IO column equilibrated with phosphate-buffered saline (PBS) (10 mM sodium phosphate containing 154 mM NaC!, FIGURE 2. Schema for the synthesis of 3-AcDON-protein conjugates used as the immunogen and coating antigens. A is the parent compound, 3-AcDON. B1 to B4 are toxin derivatives: 3-AcDON-HS (B1), 3-AcDON-HG (B2), 3-AcDON-MC (B3), and 3-AcDON-CMO (B4). C1 to C4 are the activated forms of the derivatives that were synthesized using the NHS (C1) or CD! (C2 to C4) methods. D 1to D4 are toxin-protein conjugates that were used as the immunogen or the coating antigens: 3-AcDON-HS-HSA ( 
Antibody production
For the primary immunization, the immunogen (3-AcDON-HS-HSA, Figure 2 , D 1) was emulsified with CFA (l :2, vol/vol) and each of four Dutch-belted rabbits was immunized with 250 Ilg of conjugate by multisite intradermal injections. Animals were boosted intramuscularly at 4-to 5-week intervals with 125 Ilg of the same immunogen mixed with IFA. Blood was collected from the marginal ear vein two weeks after each boosting. After coagulation, sera were isolated by centrifugation, divided into 0.5-ml aliquots and stored at -20°C. Anti-3-AcDON titers were determined in the sera using the indirect noncompetitive ELISA described below.
Preparation of coating antigens
Covalent coupling of 3-AcDON to OVA via a hemiglutarate bridge (Figure 2 , B2 to D2). The 3-AcDON-hemiglutarate derivative (3-AcDON-HG, B2) was synthesized in a manner similar to that described for the 3-AcDON-HS, except that glutaric anhydride instead of succinic anhydride was used (37) . The derivative was then conjugated to OVA using the cm method (10, 21, 33) with modifications: 4.4 mg of 3-AcDON-HS and 2.5 mg of cm were dissolved in 250 III of dimethylformamide (DMF). OVA (45 mg) was dissolved in 2.5 ml of 0.05 M boric acid-borax buffer (pH 9.2). The solution with activated toxin was added dropwise to the aqueous protein solution while stirring. The mixture was allowed to react for 2 h at room temperature and the conjugate, 3-AcDON-HG-OVA (D2), was purified and stored as described for the immunogen.
Conjugation of 3-AcDON to HSA and OVA via an O-methylcarboxyl bridge (Figure 2 , B3 to D3h and D30). The hydroxyl group at the C-15 position of 3-AcDON molecule was converted to a carboxyl group by the carboxymethylation method (J 7, 41). Briefly, 3.4 mg of toxin and 2.0 mg of iodoacetic acid were dissolved in 1.5 ml of chloroform containing an excess of active solid sodium. The reaction mixture was kept in the dark at room temperature for 18 h followed by drying under N2 and redissolving in 5 ml of chloroform. After washing three times, each with 20 ml of 0.1 N HCl, the organic phase was evaporated under N2 followed by further drying in a vacuum rotary evaporator (Savant AS-160, Savant Instruments Inc. Farmingdale, NY, USA). The unmodified 3-AcDON and the reaction product, 15-(O-1-methylcarboxyl)-3-AcDON (3-AcDON-MC, Figure 2 , B3) were then subjected to normal-phase (silica) TLC in a solvent system consisting of toluene, ethyl acetate, and fumaric acid mixed in the ratio of 6:3:1 (vol/vol/vol). After chromatography, the plate was sprayed with p-anisaldhyde followed by heating at l30°C for 8 to 10 min. Each compound migrated as a single spot with the Rf values being 0.38 and 0.45 for 3-AcDON and 3-AcDON-MC, respectively. The structure of the carboxymethylated derivative was further characterized by lH nuclear magnetic resonance (lH NMR, Bruker, AM-300, Department of Chemistry, University of Manitoba) and the presence of an additional single peak at 83.55 ppm, 1.8H (-CH2COOH -) was confirmed. 3-AcDON-MC was then conjugated to HSA and OVA by the CDI method as described above using a toxin-to-protein molar ratio of 20: 1.
Conjugation of 3-AcDON to OVA via an (O-carboxymethyl)oxime bridge (Figure 2 , B4 to D4). A carboxyl group was introduced into 3-AcDON in place of the carbonyl group at the C-8 position using an oximation reaction (6, 11) modified in a following way: 4.3 mg of carboxymethoxylamine hemihydrochloride were dissolved in 100 III of 1M sodium carbonate and 900 III of methanol containing 3.4 mg of 3-AcDON were added. The reaction was carried out at 6SOC for 5 h and then the mixture was cooled on ice. Five milliliters of 0.1 N HCl were then added and the reaction product, 3-AcDON-8-(O-carboxymethyl)oxime (3-AcDON-CMO, B4), was extracted with 10 ml of ethyl acetate. The extract was dried and the derivative was tested by TLC using the conditions described above. The Rf value of the derivative was 0.42. The identity of the derivative was further confirmed using mass spectrometry with the mlz being 411 (EI-MS, VG 7070E-HF, University of Manitoba Mass Spectrometry Centre). This derivative was conjugated to OVA by the CDI method using a molar ratio of OVA to toxin of 20: 1. The protein content of each conjugate was determined by the Bradford method (7).
Preparation of Acetylated Deoxynivalenol (AcDON) and Nivalenol (AcNIV)
Deoxynivalenol was subjected to acetylation (42) with modifications. In brief, 2 mg of DON dissolved in 0.4 ml of acetonitrile were reacted with 50 III of acetic anhydride and 100 III of I-methylimidazole in a water bath at 6SOC for 30 min. After washing with distilled water, the product was extracted with 5 ml of chloroform and evaporated to dryness. The dry residue was redissolved in 1 ml of methanol. The extent of the reaction was assessed by TLC and the acetylated product was used in the competitive ELISA. Acetylation of nivalenol was performed using the same procedure.
Indirect ELISA
Noncompetitive and competitive antibody-capture ELISAs were performed as outlined by Harlow and Lane (16) . The micro titer plates were coated with different coating conjugates: 3-AcDON-HG-OVA (D2), 3-AcDON-MC-OVA (D3o), 3-AcDON-MC-HSA (D3h), or 3-AcDON-CMO-OVA (D4) at various concentrations as indicated in each experiment. The conjugates were dissolved in 0.05 M carbonate-bicarbonate buffer (pH 9.6) and 100 III were added to each well of the plates. The plates were incubated at 37°C for 2 h followed by washing three times in PBST (PBS containing 0.05% [vol/vol] Tween 20). They were then blocked at 37°C for 2 h with 4% (wt/vol) skim milk dissolved in PBS buffer to cover the free binding sites that remained on the plates. After blocking, the plates were washed three times with PBST and dried. The coated and blocked plates could be stored with covers at -20°C for several weeks until used. For the noncompetitive ELISA, rabbit antisera were subjected to threefold serial dilutions in dilution buffer, i.e., PBS with 1% (wt/vol) skim milk solution. Each antibody dilution was added to the plates (100 III per well) in triplicates and incubated at 37°C for 1 h. For the competitive ELISA, 45 III of PBS and 5 III of toxin standards prepared in methanol together with 50 III of an optimal dilution of selected antiserum were mixed to yield final toxin concentrations ranging from 0 to 5 Ilg/ml. The mixtures were preincubated at 4°C overnight, added to the precoated plate (100 III per well), and reacted at 37°C for 1 h. For both assays, after the washing and drying steps, 100 III of alkaline phosphatase-conjugated anti-rabbit IgG diluted 1:5,000 in dilution buffer were added to all wells and incubated at 37°C for 2 h. After the plates were washed extensively and emptied, enzyme substrate was added. The substrate, pNPP, was dissolved in diethanolarnine (DEA) buffer (10% vol/vol DEA and 1 mM MgC12, pH 9.8) to yield a concentration of 1 mg/ml and 100 III of this substrate solution was applied to each well. The plate was incubated at 37°C for 30 to 40 min. This yielded an absorbance at 405 nm of 1.2 to 1.5, except for the plate coated with 3-AcDON-CMO-OVA (D4). The absorbance was read on Bio-Rad Model 450 microplate Reader (Bio-Rad, Fort Richmond, CA, USA). The antibody titers were defined as the reciprocal dilutions of antisera corresponding to 0.4 absorbance units at 405 nm. The results of the competitive ELISAs were expressed as inhibition curves by plotting toxin concentrations (ng/ml) against the relative absorbance (% B/Bo) using a graphic plotting program (Fig. P Software Co., Durham, NC and Biosoft, Miltown, NY, USA). The equation for the standard curve was obtained by fitting the data to a four-parameter logistic equation (21, 26) . The sensitivity (50% inhibitory concentration, IC50) for the assay was defined as the toxin concentration which caused a 50% decrease in maximal absorbance. The IC50 as shown in Table 2 was determined by the indirect competitive ELISA on plates coated with 10 f.lg/ml of 3-AcDON-MC-OVA using anti-3-AcDON antiserum at a dilution of 1:6,000. The detection limit for the toxin was defined as the toxin concentration which caused a decrease in absorbance that was equal to two standard deviations (SD) as calculated from the maximal absorbance value. The three-dimensional molecular images were obtained using PCMODEL from Molecular Modelling Software (Serena Software, Bloomington, IN, USA).
Quantitation of 3-AcDON in toxin-spiked barley
Barley (1 kg) was ground in a Cyclotec mill (Tecator AB, Hoganas, Sweden) and passed through a I-mm-aperture screen. The toxin, 3-AcDON, was dissolved in methanol at concentrations of 10, 2.5, 0.625, 0.156, 0.078, 0.039 and 0 f.lg/ml and 100-g aliquots of barley were spiked with 10 ml of each solution to yield final concentrations of 1000, 250, 62.5, 15.6,7.8,3.9 and 0 ppb (ng of 3-AcDON per g of barley), respectively. After extensive mixing and drying, 4 g of each sample were mixed with 20 ml of extraction solvent (i.e., 84:16 [vol/vol] acetonitrile and water containing 4% KCI [5, 35] ) followed by vigorous shaking for 30 min at room temperature. After centrifugation (10,000 X g, 15 min, 4°C), the supernatant was collected and assayed using the indirect competitive ELISA. It was performed on plates coated with 10 flg/ml of 3-AcDON-MC-OVA using anti-3-AcDON antiserum at a dilution of 1:6,000. In the quantification assays, each well contained 40 fll of PBS,S fll of acetonitrile,S fll of the extract from barley that was spiked with the toxin and 50 fll of antiserum. The reference standards were assayed at the same time with each well containing 40 fll of PBS, 5 fll of the 3-AcDON standards prepared in acetonitrile,S f.llof extract from the toxin-free barley sample, and 50 f.llof antiserum.
RESULTS
Antibody responses were detected in the sera of all immunized rabbits 5 weeks after the initial injection. High serum titers (greater than 100,000) were observed at week nine of immunization whereas preimmunized sera of the same animals were negative in the noncompetitive ELISA when 3-AcDON-HG-OVA was used as the coating antigen (data not shown). The serum with highest titer and sufficient quantity was used for immunoassay development.
Although the antisera with high titers indicated the presence of specific anti-3-AcDON antibodies, initial competitive ELISA experiments were not successful when 3-AcDON-HG-OVA was used as the coating antigen ( Figure  3 , D2). Pretreatment of antisera with a 0.5% (wt/vol) heat-denatured HSA solution to absorb the anti-carrier antibody population was not effective. Subsequently, competitive ELISAs were performed using coating antigens that had the following characteristics in respect to the immunogen ( Figure 2 gate, 3-AcDON-MC-OVA (D30), at a concentration of 10 flg/mI was selected as the coating conjugate and the antibody was diluted 1:6,000 for subsequent assays, as it provided an inhibition curve having a steep slope, minimal background interference (3% of maximal absorbance) and suitable time for color development (a maximum absorbance of 1.2 to 1.4 was obtained in 30 min at 37°C). The assay had a high sensitivity for 3-AcDON with the ICso being 0.21 ng/mI and the detection limits being 0.01 ng/mI. The standard inhibition curve was linear over a range of 3-AcDON concentrations (0.05 to 10 ng/ml) thereby allowing the quantitation of the toxin within this range (Figure 4, curve A) .
The high specificity of the assay, which represents the ability of the test system to differentiate among structurally similar compounds, is illustrated by the low degree of cross-reactivity obtained with different DON analogs and most of the other trichothecenes ( Table 2 ). The competitive ELISA using anti-3-AcDON antibodies had 4.6 and 0.01 % cross-reactivity with 15-AcDON and DON, respectively. No cross-reactivities were obtained with any other trichothecenes except for two acetylated forms of the toxins, acetylated DON (917%) and acetylated nivalenol (24.5%). The result indicated that the antibody strongly recognized the C-3 acetyl side group of the 3-AcDON and that the C-8 carbonyl moiety also played a role in this recognition. This assay system, therefore, can be considered to be highly specific for 3-AcDON detection with the exception of acetylated DON.
The detection limit for 3-AcDON in spiked barley was approximately 16 ppb and the recovery of toxin was more than 83% at toxin concentrations ranging from 16 to 1000 ppb (Table 3 ). Comparative studies demonstrated that the presence of acetonitrile influenced the assay but there was no apparent matrix influence on the standard curve (data not shown). As a result, 3-AcDON was readily quantitated in barley with good recoveries without any cleanup or concentration treatments provided that the standard solutions contained the same concentration of acetonitrile as the analytes. ..!!! 10 G)
•... 0 0 dilutions of antisera were determined using a checkerboard titration test. The optimal concentrations of the coating conjugates were 5, 10, 10, and 25 flg/ml for D2, D3h, D30, and D4, with the corresponding dilutions of antiserum being 1:80,000, 6,000, 6,000, and 800, respectively. The results demonstrated that the sensitivities and noninhibitable background of the competitive assays were markedly influenced by the nature of the coating conjugates ( Figure 3 ). For example, the maximum inhibition was 24 and 65% when the plates were coated with 3-AcDON-HG-OVA (D2) or 3-AcDON-MC-HSA (D3h), respectively. Complete inhibition with the 3-AcDON, however, was achieved when the coating conjugate was 3-AcDON-MC-OVA (D30), a conjugate that contained a heterologous protein and a heterologous linkage group. Using this system it was possible to quantitatively detect 3-AcDON in buffer solution at the nanogram level. In another heterologous system where the plates were coated with 3-AcDON-CMO-OVA (D4), a stronger inhibition response was observed than that seen with the previous conjugate (D30), but there was not sufficient amount of antibody bound to the plate to give a strong signal in toxin-free solutions even when a high quantity of the antibody (1 :800 dilution) and a high concentration of coating antigen (25 flg/ml) were used. There was also a marked difference in the ability of 3-AcDON and two of its derivatives to compete with 3-AcDON-MC-OVA for the binding of the antibodies (Figure 4) . The ICso were 0.012, 0.21, and 110 ng/ml for 3-AcDON-HG (B2), 3-AcDON (A) and 3-AcDON-CMO (B4), respectively. These results suggest that the binding of antibody to 3-AcDON-HG was 18 and 9,000 times greater than that of 3-AcDON and 3-AcDON-CMO and that 3-AcDON compared to 3-AcDON-HG-HSA competed weakly for the binding of antibody when the latter was used as the coating conjugate.
On the basis of these results, the heterologous conju- 
DISCUSSION
Mycotoxins are low-molecular-weight compounds and, like other haptens, must be chemically coupled to a protein carrier to elicit an antibody response in host animals (9) . In the present study, the immunogen was produced by linking the C-15 hydroxyl group of 3-AcDON to HSA through a hemisuccinate ester bridge (22, 37) . The characteristics of the derivative as determined by TLC were in agreement with those reported previously (37) and indicated that the derivative was a single compound, 3-AcDON-HS. Usleber et al. (37) demonstrated on the basis of lH NMR that only the C-15 hydroxyl group was derivatized. Several other studies have also shown that the C-15 hydroxyl group of 3-AcDON or DON is highly reactive, whereas the C-7 hydroxyl group is less reactive due to its secondary character and the formation of a hydrogen bond with the C-8 ketone group (15, 24, 27, 32) .
The use of 3-AcDON-HG-OVA (a conjugate with a homologous linkage and a heterologous carrier protein) as the coating conjugate in the indirect competitive antibody capture ELISA yielded high background values, as free 3-AcDON was not able to effectively inhibit the reaction between the conjugate and the antiserum. The uninhibitable reaction was probably caused by the interaction of a subpopulation of antibodies with the ester bridge (40) . The recognition of a chemical bridge by anti-hapten antibodies has been referred to as "bridge binding"; it was originally observed in the steroid immunoassay (25) and subsequently noted by other researchers (14, 21, 31, 39, 40) . Previously developed immunoassays for DON and 3-AcDON have also utilized antibodies elicited by immunogens where toxins and proteins were linked via a hemisuccinate ester bridge and the competitive inhibition was achieved by the use of a plate coating conjugate that had a hemiglutarate instead of hemisuccinate bridge (20, 37) . This approach did not, however, solve the problem in the current research as a high background with a very low degree of inhibition still occurred when a conjugate of this type was used for plate coating. This suggested that the binding of the bridge determinants by this antibody could not be reduced simply by altering the length of the bridge. Therefore, to eliminate the binding of antibody to the linking portion of the conjugate, alternative chemistries including carboxymethylation of C-15 hydroxyl group and the oximation of the C-8 carbony I group were used to produce coating antigens with different bridging structures and/or sites of attachment. It was assumed, as suggested for the esterification reaction, that the hydroxyl group at the C-15 position was the primary substrate in the carboxymethylation reaction (15, 27) . Assays using these conjugates yielded inhibition curves with much greater sensitivities and much lower background values (3% maximum absorbance) compared to those obtained by the use of the coating antigen containing the hemiglutarate bridge (Figure 3 ). The assay with the oxime bridge conjugate, however, was impractical as it required more than 6 h to develop a suitable absorbance value. This low rate of reaction may be attributed to the lack of recognition of the C-8 site of 3-AcDON, as the C-8 carbonyl group at this site was modified in 3-AcDON-CMO-OVA (D4). The C-8 site, however, was left intact in the conjugates containing either the hemisuccinate (B 1), hemiglutarate (B2), or the methylcarboxyl bridge (B3, Figure 5 ); therefore, antibodies raised against the immunogen prepared from B 1 (3-AcDON-HS) more readily recognized the conjugates derived from B2 (3-AcDON-HG) or B3 (3-AcDON-MC) than that from B4 (3-AcDON-CMO).
The observation that the antibody had a much higher (ninefold) reactivity toward acetylated DON than 3-AcDON ( Table 2) suggests that the assay also would be suitable for monitoring the entire group of DON toxins. This could be achieved by converting DON, and all its acetylated analogs, to the acetylated form of DON using the acetylation procedure described in Materials and Methods. Anti-DON antibodies produced by other researchers have also exhibited a high cross-reactivity towards acetylated DON derivatives and have been used for the detection of the DON-type mycotoxins (42, 45) .
Barley was used as the agricultural matrix in the study as it is a m~or agricultural crop and a common substrate of ;0 0 )=0 the Fusarium contamination. The hull part of the grain makes it difficult to visually differentiate between the head-blight-infected and uninfected barley; therefore reliable screening for DON-type toxins in this grain is of a particular importance. The ability to readily detect 3-AcDON at a concentration as low as 16 ppb in spiked barley shows that the assay can be used to quantitatively monitor for the presence of this toxin in naturally contaminated grain. In summary, rabbit polyclonal antibodies were produced against 3-AcDON by hemisuccinate derivatization of the C-15 hydroxyl group. The ester linkage (hemisuccinate bridge) containing conjugate was shown to be adequate for antibody production but was not suitable as a coating antigen in the current study even when a different length linkage (hemiglutarate) was used. Two other chemistries were used to produce 3-AcDON-protein carrier conjugates containing different bridging groups. The use of a heterologous coating conjugate that contained an O-methylcarboxyl bridge significantly increased the sensitivity of the ELISA and reduced the noninhibitable background to a nearly zero relative absorbance value.
